PPT vs. HQL, SOR, MIY, MHN, PMO, MCI, TYG, KTF, RFI, and ASG
Should you be buying Putnam Premier Income Trust stock or one of its competitors? The main competitors of Putnam Premier Income Trust include Abrdn Life Sciences Investors (HQL), Source Capital (SOR), BlackRock MuniYield Michigan Quality Fund (MIY), BlackRock MuniHoldings New York Quality Fund (MHN), Putnam Municipal Opportunities Trust (PMO), Barings Corporate Investors (MCI), Tortoise Energy Infrastructure (TYG), DWS Municipal Income Trust (KTF), Cohen & Steers Total Return Realty Fund (RFI), and Liberty All-Star Growth Fund (ASG). These companies are all part of the "investment offices, not elsewhere classified" industry.
Putnam Premier Income Trust (NYSE:PPT) and Abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, community ranking, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk.
42.8% of Putnam Premier Income Trust shares are owned by institutional investors. Comparatively, 32.2% of Abrdn Life Sciences Investors shares are owned by institutional investors. 10.1% of Abrdn Life Sciences Investors shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Putnam Premier Income Trust received 46 more outperform votes than Abrdn Life Sciences Investors when rated by MarketBeat users. However, 68.35% of users gave Abrdn Life Sciences Investors an outperform vote while only 66.20% of users gave Putnam Premier Income Trust an outperform vote.
Putnam Premier Income Trust has a beta of 0.34, suggesting that its share price is 66% less volatile than the S&P 500. Comparatively, Abrdn Life Sciences Investors has a beta of 0.71, suggesting that its share price is 29% less volatile than the S&P 500.
Putnam Premier Income Trust pays an annual dividend of $0.31 per share and has a dividend yield of 9.0%. Abrdn Life Sciences Investors pays an annual dividend of $1.33 per share and has a dividend yield of 10.1%.
In the previous week, Abrdn Life Sciences Investors had 10 more articles in the media than Putnam Premier Income Trust. MarketBeat recorded 14 mentions for Abrdn Life Sciences Investors and 4 mentions for Putnam Premier Income Trust. Abrdn Life Sciences Investors' average media sentiment score of 1.58 beat Putnam Premier Income Trust's score of 0.98 indicating that Abrdn Life Sciences Investors is being referred to more favorably in the news media.
Summary
Abrdn Life Sciences Investors beats Putnam Premier Income Trust on 7 of the 10 factors compared between the two stocks.
Get Putnam Premier Income Trust News Delivered to You Automatically
Sign up to receive the latest news and ratings for PPT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Putnam Premier Income Trust Competitors List
Related Companies and Tools
